MeSH term
Frequency | Condition_Probility | Animals | 4 | 0.0 |
Humans | 17 | 0.0 |
Research Support, Non-U.S. Gov't | 6 | 0.0 |
Aged | 4 | 0.0 |
Down-Regulation | 3 | 0.0 |
*Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Kallikreins/*biosynthesis | 2 | 33.0 |
Male | 5 | 0.0 |
Middle Aged | 5 | 0.0 |
Prognosis | 5 | 0.0 |
Tumor Markers, Biological/*analysis | 3 | 0.0 |
Female | 10 | 0.0 |
*Gene Expression Profiling | 2 | 0.0 |
Molecular Sequence Data | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 4 | 0.0 |
Adult | 5 | 0.0 |
Kallikreins/*genetics/metabolism | 2 | 40.0 |
Survival Analysis | 2 | 0.0 |
Survival Rate | 2 | 0.0 |
Tumor Markers, Biological/*genetics/metabolism | 2 | 10.0 |
Breast Neoplasms/*genetics | 2 | 0.0 |
RNA, Messenger/analysis | 3 | 0.0 |
Mice | 2 | 0.0 |
Gene Expression | 3 | 0.0 |
Chromatography, Gel | 2 | 0.0 |
Amino Acid Sequence | 2 | 0.0 |
Comparative Study | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Kallikreins/biosynthesis/*genetics | 2 | 33.0 |
Aged, 80 and over | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
